Serial estimation of serum albumin and its role in traumatic brain injury patients

Background: Serum albumin is routinely measured; cheap and easily available test even in remote areas laboratories. Albumin is the major protein of human plasma and one of the negative acute phase reactants reported to fall as a component of metabolic response to injury or infection, independent of the nutritional status. Even though this has also been noted in patients with head injury and its overall significance with respect to neurological outcome following head injury are yet to be established. Aims and Objectives:  To assess the role of serum albumin in outcome of head injury patient. Material and Methods:  This is a prospective case control study. Total 200 cases of traumatic brain injury [152 male and 48 female] were studied in NRS Medical College, Kolkata from September 2012 to October 2013. Serum albumin estimation, along with clinical and radiological data was collected. Serum albumin was compared between among various subgroups and outcome was assessed by Glasgow Coma Scale at 6 months. Results: In present study 86(43%) patients  having hypoalbuminemia (< 3.5gm/dl)  and falling trend in admission serum albumin levels from day 1 to 10th  day with decrement in GCS was statistically highly significant (p < 0.001) as hypoalbuminemia  was noted in 68%, 39.65 and 33.43%  patients with severe, moderate and mild head injury respectively. The present study  was showed  that female TBI patients having less no. of hypoalbuminemia compare to male as 77.7%, 45.4%, 31.4% male and 42.8%, 28.5%, 27.2% female having hypoalbuminemia (< 3.5gm/dl) in severe, moderate and mild head injury respectively and statistically significant  difference in severe and moderate group. Conclusion : The serial estimation of serum albumin in traumatic brain injury patients provides the treating doctor an insight in the prognosis of the patient so that they can be managed aggressively. Asian Journal of Medical Sciences Vol.7(4) 2016 31-38

[1]  A. Young,et al.  Mechanisms and implications of hypoalbuminemia in head-injured patients. , 1988, Journal of neurosurgery.

[2]  A. Young,et al.  The acute-phase response of the brain-injured patient. , 1988, Journal of neurosurgery.

[3]  J. Schittny,et al.  Molecular architecture of basement membranes , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  R. Brant,et al.  Nonrespiratory predictor of mechanical ventilation dependency in intensive care unit patients. , 1996, Critical care medicine.

[5]  R. Kishen,et al.  The prognostic value of serial measurements of serum albumin concentration in patients admitted to an intensive care unit , 1996, Anaesthesia.

[6]  G. Park,et al.  Serum albumin and colloid osmotic pressure in survivors and nonsurvivors of prolonged critical illness , 1998, Anaesthesia.

[7]  R. Busto,et al.  Posttreatment with high-dose albumin reduces histopathological damage and improves neurological deficit following fluid percussion brain injury in rats. , 1999, Journal of neurotrauma.

[8]  G. Park,et al.  The role of albumin in critical illness. , 2000, British journal of anaesthesia.

[9]  R. Busto,et al.  Human Albumin Therapy of Acute Ischemic Stroke: Marked Neuroprotective Efficacy at Moderate Doses and With a Broad Therapeutic Window , 2001, Stroke.

[10]  P. Reilly,et al.  Brain injury: the pathophysiology of the first hours.'Talk and Die revisited' , 2001, Journal of Clinical Neuroscience.

[11]  T. Buckley,et al.  Association of Serum Albumin Concentration and Mortality Risk in Critically Ill Patients , 2002, Anaesthesia and intensive care.

[12]  R. Berger The Use of Serum Biomarkers to Predict Outcome After Traumatic Brain Injury in Adults and Children , 2006, The Journal of head trauma rehabilitation.

[13]  David K Menon,et al.  Serum albumin level as a predictor of outcome in traumatic brain injury: potential for treatment. , 2008, The Journal of trauma.

[14]  L. Koskinen,et al.  Fluid therapy and the use of albumin in the treatment of severe traumatic brain injury , 2009, Acta anaesthesiologica Scandinavica.

[15]  D. Manju,et al.  Prospective longitudinal study of biochemical changes in critically ill patients with severe traumatic brain injury: Factors associated and outcome at 6 months , 2010, Indian Journal of Neurotrauma.

[16]  H. Ralay Ranaivo,et al.  Albumin causes increased myosin light chain kinase expression in astrocytes via p38 mitogen‐activated protein kinase , 2011, Journal of neuroscience research.

[17]  Robert M MacCallum,et al.  Multivariate outcome prediction in traumatic brain injury with focus on laboratory values. , 2012, Journal of neurotrauma.

[18]  A. Pan,et al.  [Effect of albumin and hemoglobin level on prognosis of patients with uncomplicated severe traumatic brain injury: a retrospective cohort study]. , 2013, Zhonghua wei zhong bing ji jiu yi xue.

[19]  Long Bao,et al.  Serum Albumin and Prealbumin Predict the Poor Outcome of Traumatic Brain Injury , 2014, PloS one.

[20]  Prashant S. Shinde,et al.  Serum Albumin: A Prognostic Marker in Critically Ill Patients , 2016 .